Aflibercept, commonly known by the brand name Eylea, is a medication used to treat various eye conditions, primarily those related to vision problems and abnormal blood vessel growth in the eye. The primary use of Aflibercept (Eylea) is for the treatment of the following eye conditions:
Aflibercept is administered via intravitreal injections into the eye, typically performed by an ophthalmologist. These injections deliver the medication directly to the affected area of the eye. The frequency of injections and the duration of treatment may vary based on the specific eye condition and individual patient response. This treatment has been effective in helping to preserve and, in some cases, improve vision in individuals with these eye conditions. However, like all medications, Aflibercept can have potential side effects and risks, and its use should be closely monitored by a healthcare provider with expertise in ophthalmology.
Aflibercept is used to treat certain serious eye conditions (such as wet age-related macular degeneration – wet AMD, macular edema following central retinal vein occlusion, diabetic macular edema). This medication can help preserve vision and prevent blindness.